Bandaram Pharma Packtech Ltd

Bandaram Pharma Packtech Ltd has issued a clarification regarding recent price movements in its shares. The company stated that there are no significant events or price-sensitive information that could explain the increase in its stock price. This clarification is in response to a query from the exchange, referencing Regulation 30 of SEBI (LODR) Regulations, 2015. The company assures that any future material events impacting operations or share price will be promptly intimated to the exchange.

Bandaram Pharma Packtech Limited has announced the closure of its trading window for all designated persons, their immediate relatives, and connected persons. This closure is in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The trading window will be shut from July 1, 2026, until 48 hours after the declaration of the standalone and consolidated unaudited financial results for the quarter ending June 30, 2026. A board meeting will be convened to consider and approve these financial results. The company will separately inform the stock exchange about the board meeting notice.

Bandaram Pharma Packtech Ltd has issued a clarification regarding a work order received by its material subsidiary, VSR Paper and Packaging Limited. The initial disclosure mistakenly stated the order value as Rs. 37.44 crore. The company has corrected this to Rs. 27.70 crore, representing two orders from the Government of Telangana for printing and distribution of textbooks for the academic year 2026-27. The execution period for these orders is June-August 2026.

Bandaram Pharma Packtech Ltd announced the resignation of Mr. NSK Aakarsh Raj as Whole-Time Director, effective June 5, 2026. The resignation is due to other professional and personal reasons, with no material undisclosed reasons cited. The company has provided the necessary disclosures as per SEBI regulations.

Bandaram Pharma Packtech's material subsidiary, VSR Paper and Packaging Limited, has received an order from M/s S. A. Printers for supplying raw materials for printing textbooks. The order, valued at ₹3,86,85,410, involves supplying paper, board, and other materials for printing and distributing textbooks for the academic year 2026-27. The order execution period is from June to August 2026.

Bandaram Pharma Packtech Ltd's material subsidiary, VSR Paper and Packaging Limited, has received an order from M/s Vijayaa Print Solutions for supplying raw materials for printing textbooks. The order, valued at ₹5,86,97,217, is for the academic year 2026-27 and is to be executed between June and August 2026. This constitutes a domestic work order.

Bandaram Pharma Packtech's material subsidiary, VSR Paper and Packaging Limited, has received two work orders from the Government of Telangana for printing and distributing textbooks for the academic year 2026-27. The total order value is ₹37,44,33,407.

Bandaram Pharma Packtech Ltd has scheduled a Board of Directors meeting on May 30, 2026, to consider and approve the audited financial statements (standalone and consolidated) for the quarter and year ended March 31, 2026, along with the audit report for the same period. The meeting will also address any other business with the chair's permission.

Bandaram Pharma Packtech Ltd. has called for an Extra-Ordinary General Meeting (EGM) to be held on 27.04.2026 at 11:00 a.m. The meeting will be conducted through Video Conferencing (VC) or Other Audio-Visual Means (OAVM) facility. The EGM will discuss the appointment of Mr. Eswar Reddy Putturu as an Independent Director, and the approval of material related party transactions with VSR Paper and Packaging Limited, a subsidiary company.

In a recent board meeting held on 03.04.2026, Bandaram Pharma Packtech Limited approved material related party transactions with its subsidiary company, VSR Paper and Packaging Limited. The decision will be presented for approval in an Extra-Ordinary General Meeting scheduled on 27.04.2026 at 11.00 a.m. The meeting will be conducted via video conference or other audio-visual means due to the ongoing pandemic situation.